DE69527140D1 - Wirkstoff zur prävention oder behandlung von osteoporose - Google Patents

Wirkstoff zur prävention oder behandlung von osteoporose

Info

Publication number
DE69527140D1
DE69527140D1 DE69527140T DE69527140T DE69527140D1 DE 69527140 D1 DE69527140 D1 DE 69527140D1 DE 69527140 T DE69527140 T DE 69527140T DE 69527140 T DE69527140 T DE 69527140T DE 69527140 D1 DE69527140 D1 DE 69527140D1
Authority
DE
Germany
Prior art keywords
preventing
active substance
treating osteoporosis
osteoporosis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69527140T
Other languages
English (en)
Other versions
DE69527140T2 (de
Inventor
Atsutane Ohta
Toshio Takizawa
Takashi Adachi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13389532&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69527140(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Application granted granted Critical
Publication of DE69527140D1 publication Critical patent/DE69527140D1/de
Publication of DE69527140T2 publication Critical patent/DE69527140T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE69527140T 1994-03-15 1995-03-13 Wirkstoff zur prävention oder behandlung von osteoporose Revoked DE69527140T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6068987A JPH07252156A (ja) 1994-03-15 1994-03-15 骨粗鬆症予防治療材
PCT/JP1995/000413 WO1995024909A1 (fr) 1994-03-15 1995-03-13 Agent de prevention ou de traitement de l'osteoporose

Publications (2)

Publication Number Publication Date
DE69527140D1 true DE69527140D1 (de) 2002-07-25
DE69527140T2 DE69527140T2 (de) 2003-02-20

Family

ID=13389532

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69527140T Revoked DE69527140T2 (de) 1994-03-15 1995-03-13 Wirkstoff zur prävention oder behandlung von osteoporose

Country Status (7)

Country Link
US (1) US5900255A (de)
EP (1) EP0753302B1 (de)
JP (1) JPH07252156A (de)
DE (1) DE69527140T2 (de)
ES (1) ES2179098T3 (de)
TW (1) TW400232B (de)
WO (1) WO1995024909A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10108647A (ja) * 1996-10-08 1998-04-28 Meiji Seika Kaisha Ltd 胃切除術後患者用ミネラル補給材
ES2251212T3 (es) * 1998-03-06 2006-04-16 Meiji Seika Kaisha, Ltd. Agentes para prevenir/tratar la osteoporosis.
US6241997B1 (en) * 1998-03-16 2001-06-05 Smtm Group. Llc Chewable calcium supplement and method
GB9906009D0 (en) * 1999-03-16 1999-05-12 Nycomed Pharma As Product
US6436446B1 (en) * 1999-07-30 2002-08-20 Pharmavite Llc Composition for increasing bone density
US6846496B1 (en) * 1999-10-15 2005-01-25 Orion Corporation Treatment of osteoporosis
EP1228764A1 (de) * 2001-02-01 2002-08-07 EnergyBalance AG Calciumkomposition mit Oligofructose
US6887897B2 (en) 2001-07-31 2005-05-03 Mission Pharmacal Company Calcium glutarate supplement and phosphorus binder
US8663679B2 (en) 2004-04-29 2014-03-04 Abbott Laboratories Compositions for improving breast health in women
US7435431B2 (en) * 2004-07-28 2008-10-14 Abbott Laboratories Method for controlling body weight in estrogen-insufficient women
US7601370B2 (en) * 2004-07-28 2009-10-13 Abbott Laboratories Method for controlling body weight in estrogen-insufficient women
KR20070050458A (ko) * 2004-07-28 2007-05-15 아보트 러보러터리즈 영양섭취용 조성물 및 골다공증의 치료 또는 예방 방법
US20060029641A1 (en) * 2004-08-05 2006-02-09 Keller Nathan I Calcium and magnesium nutritional supplement
JP4588403B2 (ja) * 2004-10-04 2010-12-01 森永乳業株式会社 カルシウム・マグネシウム含有組成物の製造方法
JP2006111582A (ja) * 2004-10-15 2006-04-27 Suntory Ltd カルシウム含有顆粒の製造方法
EP1930012B1 (de) * 2005-09-27 2018-05-23 Asahi Kasei Kabushiki Kaisha Cellooligosaccharid enthaltende zusammensetzung
JP5349744B2 (ja) 2005-12-19 2013-11-20 松谷化学工業株式会社 ミネラル吸収促進剤、食品及び飼料
JP5122766B2 (ja) 2006-06-20 2013-01-16 ユニチカ株式会社 エコール産生促進組成物
JP5371415B2 (ja) * 2008-12-24 2013-12-18 王子コーンスターチ株式会社 骨密度減少抑制組成物
EP3752168A4 (de) * 2018-02-14 2021-10-13 Profeat Biotechnology Co. Ltd. Verwendung von eisenhaltigem aminosäurechelat zur erhöhung der calciumaufnahme und knochenmasse und zur behandlung von osteoporose
JP6931231B2 (ja) * 2018-02-28 2021-09-01 ふるさと和漢堂株式会社 イリコパウダーとフルクタンパウダーを含有させた栄養補助食品

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689228A (en) * 1985-08-26 1987-08-25 University Patents, Inc. Enhanced absorption of dietary mineral components
US4867989A (en) * 1986-09-09 1989-09-19 Warner-Lambert Company Chewing gum mineral supplement
EP0346866A3 (de) * 1988-06-16 1990-07-11 Biochemie Gesellschaft M.B.H. Zusammenstellungen zur Prophylaxe der Osteoporosis
CA1337047C (en) * 1988-08-18 1995-09-19 Peter Dodd Cooper Gamma inulin compositions
JPH05238940A (ja) * 1991-05-22 1993-09-17 Pola Chem Ind Inc 生体への吸収率の高い速効用薬剤及びその製造方法
JPH04349868A (ja) * 1991-05-29 1992-12-04 Asahi Chem Ind Co Ltd ミネラル吸収促進剤
JPH04360664A (ja) * 1991-06-04 1992-12-14 Asahi Chem Ind Co Ltd ミネラル吸収性促進剤
JPH0640922A (ja) * 1991-07-19 1994-02-15 Morinaga Milk Ind Co Ltd カルシウム剤
JP2986133B2 (ja) * 1991-07-29 1999-12-06 ポーラ化成工業株式会社 ミネラル吸収促進剤
JP2596509B2 (ja) * 1992-12-11 1997-04-02 雪印乳業株式会社 新規なグルクロン酸含有オリゴ糖、その製造法及びその利用
JP3279694B2 (ja) * 1993-01-08 2002-04-30 雪印乳業株式会社 ラクチュロースオリゴ糖を有効成分とするミネラル吸収促進剤
JP3279695B2 (ja) * 1993-01-08 2002-04-30 雪印乳業株式会社 分岐ガラクトオリゴ糖を有効成分とするミネラル吸収促進剤
JP3462535B2 (ja) * 1993-08-31 2003-11-05 サントリー株式会社 ミネラル吸収促進組成物
US5431929A (en) * 1994-07-28 1995-07-11 Wm. Wrigley Jr. Company Chewing gum products using oligofructose

Also Published As

Publication number Publication date
EP0753302A1 (de) 1997-01-15
DE69527140T2 (de) 2003-02-20
JPH07252156A (ja) 1995-10-03
EP0753302B1 (de) 2002-06-19
US5900255A (en) 1999-05-04
EP0753302A4 (de) 2000-02-16
ES2179098T3 (es) 2003-01-16
TW400232B (en) 2000-08-01
WO1995024909A1 (fr) 1995-09-21

Similar Documents

Publication Publication Date Title
DE69527140D1 (de) Wirkstoff zur prävention oder behandlung von osteoporose
DE69427869D1 (de) Botulinumtoxine zur behandlung von hyperhydrosis
ATA46794A (de) Einrichtung zur behandlung von hautzonen
DE69524682T2 (de) Mittel zur Behandlung von Wunden
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69500089T3 (de) Behandlung von Geflügel
DE69421912T2 (de) Methode zur behandlung von wasser
DE3752141D1 (de) Mittel zur behandlung von neuropathie
DE69806579T2 (de) Anlage zur behandlung von nahrungsmitteln
DE69603089T2 (de) Zusammensetzung zur behandlung von mauerwerk
DE69421196D1 (de) Vorrichtung zur behandlung von überbiss
ATE227127T1 (de) Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes
DE59707519D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE69033413T2 (de) Mittel zur Behandlung von Metalloberflächen
DE69331833T2 (de) Verwendung von vitamin d-glykosiden zur behandlung oder prävention von osteoporose
DE69721756D1 (de) Paroxetine zur behandlung von depression
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
DE68907569D1 (de) Mittel zur behandlung oder vorbeugung von aids.
DE69928501D1 (de) Mittel zur vorbeugung/behandlung von osteoporose
DE69515568D1 (de) Vorrichtung zur Behandlung von lichtempfindlichem Material
DE69806062D1 (de) Kombinationstherapie zur behandlung von aids
DE69812599D1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
DE69701243T2 (de) Biologisch aktive ureido-derivate nützlich zur behandlung von multipler sklerose
ATA93695A (de) Mittel zur behandlung von strahlenschäden
DE69306260D1 (de) Behandlung von abwasser

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation